Is Nuformix plc (NFX.L) a Buy, Sell, or Hold?
LSE : NFX.L
Nuformix plc
$0.1615 GBp
$0.0 (1.89%)
- Volume
- 6.85M
- Average Volume
- 22.21M
- Market Capitalization
- $3.41M
- P/E Ratio
- 5.38
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.56
- Year Low
- $0.07
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $4.32
Company Overview
LSE
Daniel John Gooding
Biotechnology
Healthcare
NFX.L
3
GB
GBp
Liquidity Metrics
0.00
4.32
4.32
4.09
0.00
Sales & Valuation
-$
0.00
2.09
-5.51
0.00
Profitability
-$0.0004
-$652.59K
0.00%
0.00%
-83.53%
-53.59%
P/E Metrics
5.38
0.05
0.05
Analyst Price Target & Rating
2/5
0 Analysts
%
Financial Health Scores
1.37
2/9
$753.66K
$1.86M
$227.21K
-$1.51M
Key Metrics (TTM)
No key metrics data available.
Company Executives
| Name | Title |
|---|---|
| Joanne Holland | Consultant |
| Daniel John Gooding | Executive Director |
| Shaun Zulafqar | Company Secretary |
Poll Results
No votes yet today — be the first to share your view!
About Nuformix plc (LSE:NFX.L) Stock
Nuformix plc, a pharmaceutical company based in the United Kingdom, specializes in developing therapies for fibrotic diseases and cancer, primarily through the innovative strategy of drug repurposing. Its current development portfolio includes NXP001, which has advanced beyond Phase 1 trials for application in oncology supportive care. Additionally, the company is progressing NXP004, a novel variant of Olaparib, currently in its intellectual property generation stage for oncological indications, and NXP002, which is undergoing pre-clinical evaluation for the treatment of idiopathic pulmonary fibrosis. Nuformix also holds an option agreement with Oxilio Ltd. concerning NXP001 for its oncology applications. Established in 2008, the company maintains its operational base in London. ...
Frequently Asked Questions
-
What is the current Nuformix plc (NFX.L) stock price?
-
Nuformix plc(LSE:NFX.L) stock price is $0.1615 in the last trading session. During the trading session, NFX.L stock reached the peak price of $0.555 while $0.071 was the lowest point it dropped to. The percentage change in NFX.L stock occurred in the recent session was 1.89% while the dollar amount for the price change in NFX.L stock was $0.0.
-
NFX.L's industry and sector of operation?
-
The LSE listed NFX.L is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of NFX.L?
-
Joanne Holland | Consultant
Daniel John Gooding | Executive Director
Shaun Zulafqar | Company Secretary
|
| -
How many employees does NFX.L have?
-
Number of NFX.L employees currently stands at 3. NFX.L operates from 60 Gracechurch Street, London, GL EC3V 0HR, GB.
-
Link for NFX.L official website?
-
Official Website of NFX.L is: https://www.nuformix.com
-
How do I contact NFX.L?
-
NFX.L could be contacted at phone #44 1223 627222 and can also be accessed through its website. NFX.L operates from 60 Gracechurch Street, London, GL EC3V 0HR, GB.
-
How many shares of NFX.L are traded daily?
-
The average number of NFX.L shares traded daily for last 3 months was 22.21M.
-
What is the market cap of NFX.L currently?
-
The market value of NFX.L currently stands at $3.41M with its latest stock price at $0.1615